BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2177125)

  • 1. [High dose chemotherapy and autologous bone marrow transplantation for advanced germ cell tumor].
    Ishii H; Osa Y; Okano T; Isaka S; Yasuda K; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1990 Oct; 81(10):1473-9. PubMed ID: 2177125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
    Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
    Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.
    Mulder PO; de Vries EG; Koops HS; Splinter T; Maas A; van der Geest S; Mulder NH; Sleijfer DT
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):675-9. PubMed ID: 2838293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
    Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ
    Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
    Broun ER; Nichols CR; Gize G; Cornetta K; Hromas RA; Schacht B; Einhorn LH
    Cancer; 1997 Apr; 79(8):1605-10. PubMed ID: 9118046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)].
    Baume D; Pico JL; Droz JP; Ostronoff M; Azab M; Gilles E; Ghosn M; Salloum E; Gouyette A; Beaujean F
    Bull Cancer; 1990; 77(2):169-80. PubMed ID: 2156588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous toxicity of autologous bone marrow transplantation in nonseminomatous germ cell tumors.
    Linassier C; Colombat P; Reisenleiter M; Haillot O; Chazard M; Binet C; Desbois I; Lamagnere JP
    Cancer; 1990 Mar; 65(5):1143-5. PubMed ID: 2154321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.
    Nichols CR; Andersen J; Lazarus HM; Fisher H; Greer J; Stadtmauer EA; Loehrer PJ; Trump DL
    J Clin Oncol; 1992 Apr; 10(4):558-63. PubMed ID: 1312584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of refractory testicular cancer showing complete response to high-dose chemotherapy with autologous bone marrow transplantation].
    Ishii H; Osa Y; Okano T; Isaka S; Yasuda K; Shimazaki J; Komori I; Kodo H; Asano S
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3483-6. PubMed ID: 2478078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose chemotherapy with autologous bone marrow transplantation as treatment for relapsing testicular cancer].
    Suzuki K; Ohishi M; Sobajima T; Murase T; Ito H; Akatsuka Y
    Hinyokika Kiyo; 1991 Apr; 37(4):403-6. PubMed ID: 1892001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
    Droz JP; Kramar A; Biron P; Pico JL; Kerbrat P; Pény J; Curé H; Chevreau C; Théodore C; Bouzy J; Culine S;
    Eur Urol; 2007 Mar; 51(3):739-46; discussion 747-8. PubMed ID: 17084512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer.
    Droz JP; Pico JL; Ghosn M; Gouyette A; Baume D; Piot G; Ostronoff M; Theodore C; Beaujean F; Hayat M
    Eur J Cancer; 1991; 27(7):831-5. PubMed ID: 1718349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
    J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapeutic intensification in germ cell tumors].
    Droz JP; Pico JL; Ghosn M; Ostronoff M; Azab M; Theodore C; Hayat M
    Bull Cancer; 1990; 77(4):349-54. PubMed ID: 2354250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of autologous bone marrow transplantation in cancer chemotherapy].
    Tajima T; Tokuda Y; Kubota M; Ohta M; Yokoyama S; Mitomi T; Nakamura Y; Watanabe K; Murakami M; Shinozuka T
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3018-24. PubMed ID: 3056274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
    Lotz JP; André T; Donsimoni R; Firmin C; Bouleuc C; Bonnak H; Merad Z; Esteso A; Gerota J; Izrael V
    Cancer; 1995 Feb; 75(3):874-85. PubMed ID: 7828139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
    Nichols CR; Tricot G; Williams SD; van Besien K; Loehrer PJ; Roth BJ; Akard L; Hoffman R; Goulet R; Wolff SN
    J Clin Oncol; 1989 Jul; 7(7):932-9. PubMed ID: 2544687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue.
    Broun ER; Nichols CR; Kneebone P; Williams SD; Loehrer PJ; Einhorn LH; Tricot GJ
    Ann Intern Med; 1992 Jul; 117(2):124-8. PubMed ID: 1318648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
    Harstrick A; Schmoll HJ; Wilke H; Köhne-Wömpner CH; Stahl M; Schöber C; Casper J; Bruderek L; Schmoll E; Bokemeyer C
    J Clin Oncol; 1991 Sep; 9(9):1549-55. PubMed ID: 1651992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.